Overview

Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme

Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
This is a phase II study on the usage of stereotactic Gamma Knife radiosurgery as a boost to the tumor bed border zone in conjunction with the usage of bevacizumab.
Phase:
Phase 2
Details
Lead Sponsor:
Ajay Niranjan
University of Pittsburgh
Collaborator:
Genentech, Inc.
Treatments:
Bevacizumab